{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:19:57Z","timestamp":1793276397672,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01-CA206028"],"award-info":[{"award-number":["R01-CA206028"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"VCU Massey Cancer Center","award":["P30 CA016059"],"award-info":[{"award-number":["P30 CA016059"]}]},{"name":"NIH-NCI Cancer Center"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.neuropharm.2017.02.020","type":"journal-article","created":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T02:48:06Z","timestamp":1487818086000},"page":"305-315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":155,"special_numbering":"C","title":["Effects of paclitaxel on the development of neuropathy and affective behaviors in the mouse"],"prefix":"10.1016","volume":"117","author":[{"given":"Wisam","family":"Toma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Lauren","family":"Kyte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Bagdas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Alkhlaif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakir D.","family":"Alsharari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aron H.","family":"Lichtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9447-8827","authenticated-orcid":false,"given":"Zhi-Jian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egidio","family":"Del Fabbro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Bigbee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Gewirtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Imad","family":"Damaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2017.02.020_bib1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-2407-10-50","article-title":"Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study","volume":"10","author":"Arrieta","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.neuropharm.2017.02.020_bib2","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.bcp.2015.04.013","article-title":"The role of alpha5 nicotinic acetylcholine receptors in mouse models of chronic inflammatory and neuropathic pain","volume":"97","author":"Bagdas","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.02.020_bib3","series-title":"Review Cellular and Molecular Mechanisms of Pain","first-page":"267","author":"Basbaum","year":"2009"},{"key":"10.1016\/j.neuropharm.2017.02.020_bib4","first-page":"18","article-title":"Chemotherapy-induced neurotoxicity: the value of neuroprotective strategies","volume":"70","author":"Beijers","year":"2012","journal-title":"Neth. J. Med."},{"key":"10.1016\/j.neuropharm.2017.02.020_bib5","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1111\/j.1460-9568.2011.07652.x","article-title":"Terminal arbor degeneration - a novel lesion produced by the antineoplastic agent paclitaxel","volume":"33","author":"Bennett","year":"2011","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.020_bib6","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/BF00181937","article-title":"The effects of chronic antidepressant treatment in an animal model of anxiety","volume":"95","author":"Bodnoff","year":"1988","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.02.020_bib7","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1038\/srep06370","article-title":"Electrophysiological, behavioral and histological characterization of paclitaxel, cisplatin, vincristine and bortezomib-induced neuropathy in C57Bl\/6 mice","volume":"4","author":"Boehmerle","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2017.02.020_bib8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.physbeh.2013.05.012","article-title":"Factors influencing behavior in the forced swim test","volume":"118","author":"Bogdanova","year":"2013","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2017.02.020_bib9","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neulet.2014.10.014","article-title":"Chemotherapy-induced peripheral neuropathy: what do we know about mechanisms?","volume":"596","author":"Carozzi","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2017.02.020_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2017.02.020_bib11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.4103\/0976-500X.119726","article-title":"How to calculate sample size in animal studies?","volume":"4","author":"Charan","year":"2013","journal-title":"J.\u00a0Pharmacol. Pharmacother"},{"key":"10.1016\/j.neuropharm.2017.02.020_bib12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0091-3057(80)90067-2","article-title":"Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines","volume":"13","author":"Crawley","year":"1980","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2017.02.020_bib13","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1124\/mol.104.001313","article-title":"Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors","volume":"66","author":"Damaj","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.02.020_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.gore.2016.04.006","article-title":"Tumor grade and chemotherapy response in endometrioid endometrial cancer","volume":"17","author":"Davidson","year":"2016","journal-title":"Gynecol. Oncol. Rep."},{"key":"10.1016\/j.neuropharm.2017.02.020_bib15","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.biopsych.2014.04.009","article-title":"Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal","volume":"77","author":"Deng","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.02.020_bib16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/CEOR.S82194","article-title":"Nab-paclitaxel, docetaxel, or solvent-based paclitaxel in metastatic breast cancer: a cost-utility analysis from a Chinese health care perspective","volume":"7","author":"Dranitsaris","year":"2015","journal-title":"Clin. Outcomes Res."},{"key":"10.1016\/j.neuropharm.2017.02.020_bib17","first-page":"447","article-title":"Sex, gender, and pain: a review of recent clinical and experimental findings","volume":"10","author":"Fillingim","year":"2009","journal-title":"J.\u00a0Pain"},{"key":"10.1016\/j.neuropharm.2017.02.020_bib18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2165\/11630070-000000000-00000","article-title":"Pain mechanisms in patients with chronic pain","volume":"32","author":"Fornasari","year":"2012","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.neuropharm.2017.02.020_bib19","first-page":"1866","article-title":"Estimation of paclitaxel biodistribution and uptake in human-derived xenografts in\u00a0vivo with (18)F-fluoropaclitaxel","volume":"46","author":"Gangloff","year":"2005","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.neuropharm.2017.02.020_bib20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1399-6576.2007.01486.x","article-title":"Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey","volume":"52","author":"Gustorff","year":"2008","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.neuropharm.2017.02.020_bib21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrc1317","article-title":"Microtubules as a target for anticancer drugs","volume":"4","author":"Jordan","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.neuropharm.2017.02.020_bib22","first-page":"2849","article-title":"Increased penetration of paclitaxel into the brain by inhibition of P-glycoprotein","volume":"9","author":"Kemper","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neuropharm.2017.02.020_bib23","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"Animal research: reporting in\u00a0vivo experiments: the ARRIVE guidelines","volume":"160","author":"Kilkenny","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.02.020_bib24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.npep.2014.02.001","article-title":"Neuropeptides Peptidergic intraepidermal nerve fibers in the skin contribute to the neuropathic pain in paclitaxel-induced peripheral neuropathy","volume":"48","author":"Ko","year":"2014","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuropharm.2017.02.020_bib25","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1097\/j.pain.0000000000000290","article-title":"Prevention of chemotherapy-induced peripheral neuropathy by the small-molecule inhibitor pifithrin-[mu]","volume":"156","author":"Krukowski","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2017.02.020_bib26","first-page":"1","article-title":"Effects of pregabalin on the nociceptive, emotional and cognitive manifestations of neuropathic pain in mice","author":"La Porta","year":"2016","journal-title":"Eur. J. Pain (United Kingdom)"},{"key":"10.1016\/j.neuropharm.2017.02.020_bib51","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jchemneu.2016.04.006","article-title":"Axonopathy in peripheral neuropathies: Mechanisms and therapeutic approaches for regeneration","volume":"76","author":"Landowski","year":"2016","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.neuropharm.2017.02.020_bib27","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0090-8258(03)00517-1","article-title":"Carboplatin plus paclitaxel combination chemotherapy: impact of sequence of drug administration on treatment-induced neutropenia","volume":"91","author":"Markman","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.neuropharm.2017.02.020_bib28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/jncimonographs\/lgh014","article-title":"Prevalence of depression in patients with cancer","volume":"10021","author":"Massie","year":"2004","journal-title":"J.\u00a0Natl. Cancer Inst. Monogr."},{"key":"10.1016\/j.neuropharm.2017.02.020_bib29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1158\/1535-7163.MCT-08-0840","article-title":"Platinum neurotoxicity pharmacogenetics","volume":"8","author":"McWhinney","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.neuropharm.2017.02.020_bib30","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1200\/JCO.2014.56.0086","article-title":"Four-week prevalence of mental disorders in patients with cancer across major tumor entities","volume":"32","author":"Mehnert","year":"2014","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.neuropharm.2017.02.020_bib31","article-title":"Gender differences in a mouse model of chemotherapy-induced neuropathic pain","author":"Naji-Esfahani","year":"2015","journal-title":"Lab. Anim."},{"key":"10.1016\/j.neuropharm.2017.02.020_bib32","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1097\/j.pain.0000000000000171","article-title":"Effects of ketoprofen, morphine, and kappa opioids on pain-related depression of nesting in mice","volume":"156","author":"Negus","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2017.02.020_bib33","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1200\/JCO.2000.18.17.3084","article-title":"Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer","volume":"18","author":"Neijt","year":"2000","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.neuropharm.2017.02.020_bib34","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.pain.2007.10.012","article-title":"Tetrodotoxin inhibits the development and expression of neuropathic pain induced by paclitaxel in mice","volume":"137","author":"Neito","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2017.02.020_bib35","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1021\/ja4014997","article-title":"Rational design of fatty acid amide hydrolase inhibitors that act by covalently bonding to two active site residues","volume":"135","author":"Otrubova","year":"2013","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.neuropharm.2017.02.020_bib36","doi-asserted-by":"crossref","first-page":"9069","DOI":"10.1073\/pnas.0811949106","article-title":"Peripheral tumors induce depressive-like behaviors and cytokine production and alter hypothalamic-pituitary-adrenal axis regulation","volume":"106","author":"Pyter","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.02.020_bib37","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2017.02.020_bib38","first-page":"24","article-title":"The time-to-integrate-to-nest test as an indicator of wellbeing in laboratory mice","volume":"53","author":"Rock","year":"2014","journal-title":"J.\u00a0Am. Assoc. Lab. Anim. Sci."},{"key":"10.1016\/j.neuropharm.2017.02.020_bib39","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/nn1992","article-title":"The neuropathic pain triad: neurons, immune cells and glia","volume":"10","author":"Scholz","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.020_bib40","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1200\/JCO.2007.11.6699","volume":"26","author":"Seidman","year":"2008","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.neuropharm.2017.02.020_bib41","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","article-title":"Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis","volume":"155","author":"Seretny","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2017.02.020_bib42","doi-asserted-by":"crossref","first-page":"e0147620","DOI":"10.1371\/journal.pone.0147620","article-title":"Impact of genetic reduction of NMNAT2 on chemotherapy-induced losses in cell viability in\u00a0vitro and peripheral neuropathy in\u00a0vivo","volume":"11","author":"Slivicki","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2017.02.020_bib43","doi-asserted-by":"crossref","first-page":"E205","DOI":"10.1188\/09.ONF.E205-E214","article-title":"The symptom cluster of fatigue, pain, anxiety, and depression and the effect on the quality of life of women receiving treatment for breast cancer: a multicenter study","volume":"36","author":"So","year":"2009","journal-title":"Oncol. Nurs. Forum"},{"key":"10.1016\/j.neuropharm.2017.02.020_bib44","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1901\/jeab.1971.15-215","article-title":"Automated preference testing apparatus for rating palatability of foods","volume":"15","author":"Thompson","year":"1971","journal-title":"J.\u00a0Exp. Anal. Behav."},{"key":"10.1016\/j.neuropharm.2017.02.020_bib45","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/01635581.2016.1144075","article-title":"Value: changes in the detection and recognition thresholds of three basic tastes in lung cancer patients receiving cisplatin and paclitaxel and its association with nutritional and quality of life parameters","volume":"68","author":"Turcott","year":"2016","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.neuropharm.2017.02.020_bib46","first-page":"1","volume":"vol. 9","author":"Vichaya","year":"2015"},{"key":"10.1016\/j.neuropharm.2017.02.020_bib47","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1213\/ANE.0b013e3182283486","article-title":"Cannabidiol prevents the development of cold and mechanical allodynia in paclitaxel-treated female c57bl6 mice","volume":"113","author":"Ward","year":"2011","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neuropharm.2017.02.020_bib48","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1111\/bph.13469","article-title":"Diacylglycerol lipase\u202f\u03b2 inhibition reverses nociceptive behaviour in mouse models of inflammatory and neuropathic pain","volume":"173","author":"Wilkerson","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.02.020_bib49","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1158\/0008-5472.CAN-15-2525","article-title":"Sustained accumulation of microtubule-binding chemotherapy drugs in the peripheral nervous system: correlations with time course and neurotoxic severity","volume":"76","author":"Wozniak","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuropharm.2017.02.020_bib50","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.biopsych.2011.07.017","article-title":"A\u00a0time-dependent history of mood disorders in a murine model of neuropathic pain","volume":"70","author":"Yalcin","year":"2011","journal-title":"Biol. Psychiatry"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817300746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817300746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T16:22:49Z","timestamp":1658679769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390817300746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":51,"alternative-id":["S0028390817300746"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.02.020","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of paclitaxel on the development of neuropathy and affective behaviors in the mouse","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}